Type 2 Diabetes

Choosing the right drug can be a difficult decision, as cost-effectiveness and positive outcomes vary between aflibercept, bevacizumab, and ranibizumab.

Healthcare professionals may soon be able to double dip and use diabetes drugs to also treat Alzheimer’s disease, and vice versa.

Research in the medical field covers a wide range of conditions and ways to not only treat them but also prevent them. Research is being done on a new vaccine for hepatitis B which has shown to be effective in patients with diabetes.

When people think of social networks their immediate reaction may be to think of web based networks and programs. A new recent study looked at the impact of having people to turn to for patients in the early stages of diabetes treatment and beyond.

While it is not yet approved for the treatment of patients with type 1 diabetes recent studies on canagliflozin have shown it could be an option for this patient population.

A recent study found that the mechanisms of HbA1C may confound predictions of metabolic risk by vitamin D3 levels in athletes

Most patients are well-meaning and generally nice. But every now and then, you will get one who is a total pain to deal with. Maybe your patient lies to you, gets sarcastic, asks for special “favors,†or generally just pushes your buttons. We’ve all been there.

It is frustrating, to say the least, when your patients take their frustrations out on you. And, as if having to deal with an angry patient isn’t bad enough, providers now have to worry about the threat of legal action more than ever before.

There are many factors and comorbidities to consider when treating diabetes. Finding the balance of treatment through medications can determine the quality of life of patients as they navigate through the condition.

With more than 60 presentations at the American Diabetes Association's meeting AstraZeneca showed a wide range of studies all geared towards helping patients with this condition.

A secondary analysis of data from the Insulin Resistance Intervention after Stroke trial (IRIS) examined pioglitazone’s effect on diabetes prevention.

Adding liraglutide to insulin treatment for type 1 diabetes has proven to lower body weight and reduce the frequency of hypoglycemia. Potential heart risks, however, have yet to be established.

When patients enter the hospital monitoring their blood glucose can be even more important to limit the effects of hypoglycemia. If the condition does develop it can make the stays longer and more expensive for everyone involved.

The first at-home study to test the efficacy & safety of a fully automated, dual hormone (glucagon and insulin) bionic pancreas was presented at ADA.

Blood glucose monitoring is an important part of patient care no matter where it is done, but it can be particularly important in hospital settings.

The field of diabetes care is continually moving forward. Even as data was being presented at this year's meeting of the American Diabetes Association the future was at the forefront of many people's minds in an effort to help these patients even more.

Even as gastric bypass continues to be a proven surgical option in the fight against the obesity epidemic work still remains to find a therapeutic option for this patient population as well.

A study tested the impact of intensive lifestyle intervention in low-income African Americans with type 2 diabetes. Results were shared at ADA.

Investigators compared initial therapy with canagliflozin plus metformin to metformin monotherapy in drug naïve type 2 diabetes patients.

There is no question that hunger can affect a person's life, a recent study looked at the scientific aspect of this discussion and what doctors can do to help patients with this challenge.

Especially for children with diagnosed with type 1 diabetes their journey with the condition will last decades affecting not only themselves but those around them. This is also true for patients with type 2 diabetes and how they confront these challenges can affect their life outside of diabetes as well.

Patients with type 2 diabetes are especially at risk for getting the hepatitis B infection, and a new vaccine proved to work better than the current one during a phase III trial.

“Early diabetic kidney disease (DKD), including increased albumin excretion and renal hyperfiltration (HF), is common in youth with type 2 diabetes,†a collaborative team of researchers began in a poster session at the American Diabetes Association (ADA 2016) 76th Scientific Sessions in New Orleans, Louisiana.

IBM Watson Health is working on several projects of their own as well as with partners in the field to move the treatment of diabetes forward in an effort to hep as many patients as possible.

At the recent ASCO conference in Chicago it was announced that Watson Health would be used to help with cancer treatment. A similar announcement was made at the American Diabetes Association's annual meeting in New Orleans.

As the treatment of diabetes becomes more complicated with a multitude of options on the market a long time member of the medical technology community is taking a big step to help fight this epidemic.

A post hoc analysis delved further into the EXAMINE trial to evaluate the risk of cardiovascular death in all of the type 2 diabetic participants.

Everyone needs an adequate amount of sleep every night, but it should especially be a priority in pregnant women. However, there is a fine line between too much and too little sleep, but either way, both sides of the spectrum have an increase risk in gestational diabetes.

The obesity epidemic continues to grow in this country leaving the medical community to find new ways to help this patient population.

Many healthcare providers have been pushing for the approval of insulin degludec/liraglutide (IDegLira) and the latest safety and efficacy results could help finally do that.